This Biotech Stock Is Surging Over Potential COVID-19 Drug

0
659
This Biotech Stock Is Surging Over Potential COVID-19 Drug

Regeneron (REGN) is speeding up the development of a therapy against COVID-19. The drug can act as a vaccine. Investors welcomed the news.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here